VA Disability Rating for Depression (MDD) (DC 9434)

VA Disability Rating for Depression (MDD)

Major depressive disorder is rated on occupational and social impairment, using the same scale as other VA mental-health conditions.

Diagnostic code 9434 · §4.130 · Mental disorders · up to 100%

How the VA rates Depression (MDD)

The VA assigns one of these ratings for Major depressive disorder, based on the severity of your condition. These criteria are summarized from §4.130:

Rating	When it applies
100%	Total occupational and social impairment due to: gross impairment in thought processes or communication, persistent delusions or hallucinations, grossly inappropriate behavior, persistent danger of hurting self or others, inability to perform ADLs, disorientation to time or place, memory loss for names of close relatives, own occupation, or own name
70%	Deficiencies in most areas (work, school, family, judgment, thinking, mood) due to: suicidal ideation, obsessional rituals, illogical/obscure speech, near-continuous panic or depression, impaired impulse control, spatial disorientation, neglect of appearance/hygiene, difficulty adapting to stress, inability to establish effective relationships
50%	Reduced reliability and productivity due to: flattened affect, panic attacks more than once a week, difficulty understanding complex commands, impaired short/long-term memory, impaired judgment, disturbances of motivation and mood, difficulty establishing effective relationships
30%	Occasional decrease in work efficiency with intermittent inability to perform tasks due to: depressed mood, anxiety, suspiciousness, chronic sleep impairment, mild memory loss
10%	Mild or transient symptoms that decrease work efficiency only during periods of significant stress, or symptoms controlled by continuous medication
0%	Diagnosed, but symptoms not severe enough to interfere with occupational/social functioning or require continuous medication

Conditions commonly connected to Depression (MDD)

Depression (MDD) is frequently claimed alongside, or as a secondary to, these conditions. If you have any of them, they may be separately ratable:

Sleep apneaPTSDAnxiety disorderErectile dysfunctionSubstance abuse disorderHypertensionWeight gain

How to strengthen a Depression (MDD) claim

The rating you receive depends almost entirely on your evidence and your C&P exam. To put your best claim forward:

Get a current diagnosis and make sure your symptoms are documented at their worst, not your best day.
Prepare for your C&P exam — the examiner's report usually decides your rating.
If service connection isn't obvious, a nexus letter can link the condition to your service.
If this condition was caused by another rated condition, file it as a secondary claim.

Peer-Reviewed Research on Depression (MDD)

16 peer-reviewed studies linked to Depression (MDD) (diagnostic code 9434) in the VA Ready app, sourced from PubMed and the U.S. National Library of Medicine. Every citation is real and links to the source — bring them to your C&P exam or hand them to your VSO.

Meta-analysisPrimary2022
The prevalence of depression among Iran-Iraq war veterans, combatants and former prisoners of war: A systematic review and meta-analysis.
International journal of psychology · 2022
- Pooled depression prevalence in war veterans ~56 percent.
- Former POWs had substantially higher depression rates.
- Depression persisted decades after wartime exposure.
Why it matters: Supports chronicity argument for depression after combat or POW status.
View on PubMed ↗
Meta-analysisPrimary2021
The global prevalence of depression, suicide ideation, and attempts in the military forces: a systematic review and Meta-analysis.
BMC psychiatry · 2021
- Pooled global prevalence of depression in military forces ~23 percent.
- Pooled prevalence of suicidal ideation ~11 percent.
- Combat exposure and deployment were significant predictors.
Why it matters: Globally representative evidence supporting MDD service connection.
View on PubMed ↗
Meta-analysisPrimary2018
Prevalence of Mental Health Disorders in Elderly U.S. Military Veterans: A Meta-Analysis and Systematic Review.
The American journal of geriatric psychiatry · 2018
- Pooled prevalence of major depression in elderly U.S. veterans ~11 percent.
- GAD prevalence in elderly veterans ~5 percent.
- PTSD prevalence ~7 percent, higher in combat veterans.
Why it matters: Authoritative prevalence baseline for service-connected MDD/GAD/PTSD in older veterans.
View on PubMed ↗
Cross-sectionalPrimary2013
Post-traumatic stress disorder, depression, and aggression in OEF/OIF veterans.
Military medicine · 2013
- OEF/OIF veterans with PTSD had significantly higher rates of comorbid major depression.
- Combined PTSD and depression were associated with elevated aggression and impulsivity.
- Comorbid presentations predicted greater functional impairment.
Why it matters: Supports secondary service connection of MDD to PTSD in post-9/11 veterans.
View on PubMed ↗
Cross-sectionalPrimary2011
Deployment-related TBI, persistent postconcussive symptoms, PTSD, and depression in OEF/OIF veterans.
Rehabilitation psychology · 2011
- Deployment-related TBI significantly associated with persistent post-concussive symptoms, PTSD, and depression.
- Veterans with TBI had ~2x or greater risk of meeting criteria for major depression.
- PTSD partially mediated the TBI-depression relationship.
Why it matters: Supports secondary service connection of depression to in-service TBI.
View on PubMed ↗
Case-controlSupporting2024
Posttraumatic Stress Disorder and Obstructive Sleep Apnea in Twins.
JAMA Network Open · 2024
- Vietnam Era Twin Registry to test PTSD-OSA association controlling for shared genetics and early environment
- PTSD severity associated with higher OSA prevalence within twin pairs
- Causal interpretation: PTSD increases OSA risk independent of familial confounders
Why it matters: Strongest available evidence for secondary service connection of OSA to PTSD
View on PubMed ↗
Meta-analysisSupporting2023
Studying the Prevalence of PTSD in Veterans, Combatants and Freed Soldiers of Iran-Iraq War.
Psychology, health & medicine · 2023
- Pooled prevalence of PTSD in combatants ~38 percent.
- Prevalence in freed POWs substantially higher.
- Time since exposure did not reduce prevalence — chronic course.
Why it matters: Supports chronicity of combat PTSD; relevant for service connection and TDIU.
View on PubMed ↗
Cohort studySupporting2023
The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study.
Journal of Clinical Sleep Medicine · 2023
- More severe OSA attenuated PTSD response to esketamine
- OSA severity inversely correlated with PTSD improvement
- Bidirectional clinical interaction
Why it matters: OSA worsens PTSD treatment outcomes, reinforcing aggravation/secondary connection arguments
View on PubMed ↗
Systematic reviewSupporting2020
Psychological and pharmacological interventions for PTSD and comorbid mental health problems following complex traumatic events.
PLoS medicine · 2020
- Multicomponent psychological interventions (TF-CBT, EMDR) reduced PTSD symptoms with moderate-to-large effect sizes.
- Combined treatments addressing comorbid depression and anxiety produced additional benefit in complex PTSD.
- Pharmacotherapy alone produced smaller effects than psychotherapy.
Why it matters: Supports that combat veterans with comorbid depression and anxiety warrant multicomponent treatment.
View on PubMed ↗
Cohort studySupporting2020
Combat-Related PTSD and Comorbid Major Depression in U.S. Veterans: The Role of Deployment Cycle Adversity and Social Support.
Journal of traumatic stress · 2020
- Comorbid major depression occurred in over half of U.S. veterans with combat-related PTSD.
- Higher deployment cycle adversity predicted greater comorbid depression severity.
- Lower post-deployment social support was independently associated with PTSD-MDD comorbidity.
Why it matters: Strong evidence supporting secondary service connection of MDD to combat PTSD.
View on PubMed ↗
Meta-analysisSupporting2020
Epigenome-wide meta-analysis of PTSD across 10 military and civilian cohorts identifies methylation changes in AHRR.
Nature communications · 2020
- DNA methylation changes in AHRR gene associated with PTSD across 10 cohorts.
- Biological signature of PTSD persists across trauma type and cohort.
- Epigenetic markers may serve as future biomarkers.
Why it matters: Provides biological evidence supporting legitimacy of the diagnosis in disability adjudication.
View on PubMed ↗
ReviewSupporting2019
The Efficacy of Cognitive Processing Therapy for PTSD Related to Military Sexual Trauma in Veterans: A Review.
Journal of evidence-based social work · 2019
- CPT demonstrates significant efficacy for PTSD secondary to MST.
- Veterans receiving CPT show clinically meaningful symptom reduction.
- Gender-sensitive delivery improves engagement and outcomes.
Why it matters: Supports MST-related PTSD as service-connected with established treatment.
View on PubMed ↗
Meta-analysisSupporting2015
Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis.
Journal of psychiatric practice · 2015
- Benzodiazepines are ineffective for PTSD treatment and may worsen outcomes.
- Benzodiazepine use was associated with increased aggression, depression, and substance misuse in veterans with PTSD.
- Evidence supports avoiding benzodiazepines in PTSD; trauma-focused psychotherapy and SSRIs remain first-line.
Why it matters: Supports argument that veterans on benzodiazepines may have inadequately treated PTSD.
View on PubMed ↗
Meta-analysisSupporting2013
Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
The Journal of clinical psychiatry · 2013
- Psychotherapy (notably trauma-focused CBT and EMDR) produced large effect sizes for PTSD symptom reduction.
- SSRIs and SNRIs produced moderate effects; risperidone, topiramate, and venlafaxine had supportive evidence.
- Benzodiazepines lacked evidence of benefit and are not recommended for PTSD.
Why it matters: Foundational evidence supporting service-connected PTSD treatment efficacy.
View on PubMed ↗
ReviewSupporting2012
Review: managing PTSD in combat veterans with comorbid traumatic brain injury.
Journal of rehabilitation research and development · 2012
- PTSD-TBI comorbidity highly prevalent in OEF/OIF veterans; complicates treatment.
- Symptom overlap between PTSD and post-concussive syndrome can confound diagnosis.
- Integrated multidisciplinary care improves outcomes.
Why it matters: Supports secondary service connection of PTSD to documented TBI events.
View on PubMed ↗
Systematic reviewSupporting2010
Prevalence estimates of combat-related post-traumatic stress disorder: critical review.
The Australian and New Zealand journal of psychiatry · 2010
- Lifetime PTSD prevalence among Vietnam veterans 10-30 percent depending on methodology.
- Current PTSD prevalence in OEF/OIF veterans 4-17 percent.
- Higher combat exposure consistently correlated with elevated PTSD risk.
Why it matters: Authoritative prevalence data supporting combat-related PTSD as service-connected.
View on PubMed ↗

Citations are provided for general educational use and are not medical advice. The VA Ready app pairs every study with its key findings and a one-tap Claim Summary PDF appendix.

Rate this condition in the VA Ready app

Free, no account: pick this condition, see the exact 38 CFR criteria, and watch your combined rating update with real VA math — plus the 50+ filing guides and a personalized timeline.

With Pro

Walk away with a VSO-ready Claim Summary PDF (peer-reviewed evidence appendix), an Exposure Profile PDF of every presumptive your service earned, and the full criteria for all 755 conditions.

Get VA Ready for iOS Get Vet Ready for Android

Common questions

What is the VA rating for Depression (MDD)?

The VA rates Major depressive disorder under diagnostic code 9434 (§4.130). Ratings run up to 100%, assigned from the criteria in the table above based on the severity of your condition.

What diagnostic code does the VA use for Depression (MDD)?

Diagnostic code 9434, rated under §4.130 of the VA Schedule for Rating Disabilities.

Can Depression (MDD) be claimed as a secondary condition?

Yes. Depression (MDD) is commonly connected to conditions like Sleep apnea, PTSD, Anxiety disorder. A secondary claim needs a medical nexus linking it to your service-connected condition.

This page is for general informational purposes only and is not legal or medical advice. Rating criteria are summarized from 38 CFR Part 4; the VA determines actual ratings based on your evidence and exam. VA Ready is not affiliated with the U.S. Department of Veterans Affairs. Always verify current criteria at VA.gov and consult a VA-accredited representative.